Predictive scoring model of mortality in Gram-negative bloodstream infection

被引:89
作者
Al-Hasan, M. N. [1 ,2 ]
Lahr, B. D. [3 ]
Eckel-Passow, J. E. [3 ]
Baddour, L. M. [2 ]
机构
[1] Univ Kentucky, Div Infect Dis, Dept Med, Lexington, KY 40536 USA
[2] Mayo Clin, Dept Med, Coll Med, Div Infect Dis, Rochester, MN USA
[3] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA
关键词
Bacteraemia; outcome; Pitt bacteraemia score; risk factors; sepsis; COMBINATION ANTIBIOTIC-THERAPY; RISK-FACTORS; ANTIMICROBIAL THERAPY; BETA-LACTAM; BACTEREMIA; MONOTHERAPY; MANAGEMENT; FATALITY; OUTCOMES; COHORT;
D O I
10.1111/1469-0691.12085
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Mortality is a well-recognized complication of Gram-negative bloodstream infection (BSI). The aim of this study was to develop a model to predict mortality in patients with Gram-negative BSI by using the Pitt bacteraemia score (PBS) and other clinical and laboratory variables. A cohort of 683 unique adult patients who were followed for at least 28days after admission to Mayo Clinic Hospitals with Gram-negative BSI from 1 January 2001 to 31 October 2006 and who received clinically predefined appropriate empirical antimicrobial therapy was retrospectively identified. Multivariable logistic regression was used to identify independent risk factors for 28-day all-cause mortality. Regression coefficients from a multivariable model were used to develop a risk score to predict mortality following Gram-negative BSI. Malignancy (OR3.48, 95%CI1.94-6.22), liver cirrhosis (OR5.42, 95%CI2.52-11.65), source of BSI other than urinary tract or central venous catheter infection (OR5.54, 95%CI2.42-12.69), and PBS (OR1.98, 95%CI0.92-4.25 for PBS of 2-3 and OR6.42, 95%CI3.11-13.24 for PBS4) were identified as independent risk factors for 28-day mortality in patients with Gram-negative BSI. A risk-score model was created by adding points for each independent risk factor, and had a c-statistic of 0.84. Patients with risk scores of 0, 4, 8, 12 and 16 had estimated 28-day mortality rates of approximately 0%, 3%, 14%, 45%, and 81%, respectively. The Gram-negative BSI risk score described herein estimated mortality risk with high discrimination in patients with Gram-negative BSI who received clinically adequate empirical antimicrobial therapy.
引用
收藏
页码:948 / 954
页数:7
相关论文
共 27 条
[11]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[12]  
Harrell FE., 2001, Regression Modeling Strategies: with Applications to Linear Models, Logistic Regression, and Survival Analysis, V608, DOI DOI 10.2147/
[13]   Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia [J].
Kang, Cheol-In ;
Song, Jae-Hoon ;
Chung, Doo Ryeon ;
Peck, Kyong Ran ;
Yeom, Joon-Sup ;
Ki, Hyun Kyun ;
Son, Jun Seong ;
Lee, Jin Seo ;
Kim, Yeon-Sook ;
Jung, Sook-In ;
Kim, Shin-Woo ;
Chang, Hyun-Ha ;
Ryu, Seong Yeol ;
Kwon, Ki Tae ;
Lee, Hyuck ;
Jung, Dong Sik ;
Moon, Chisook ;
Heo, Sang Taek ;
Kim, Eu Suk ;
Rhee, Ji-Young .
JOURNAL OF INFECTION, 2011, 63 (05) :336-343
[14]   Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome [J].
Kang, CI ;
Kim, SH ;
Park, WB ;
Lee, KD ;
Kim, HB ;
Kim, EC ;
Oh, MD ;
Choe, KW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :760-766
[15]   THE APACHE-III PROGNOSTIC SYSTEM - RISK PREDICTION OF HOSPITAL MORTALITY FOR CRITICALLY ILL HOSPITALIZED ADULTS [J].
KNAUS, WA ;
WAGNER, DP ;
DRAPER, EA ;
ZIMMERMAN, JE ;
BERGNER, M ;
BASTOS, PG ;
SIRIO, CA ;
MURPHY, DJ ;
LOTRING, T ;
DAMIANO, A ;
HARRELL, FE .
CHEST, 1991, 100 (06) :1619-1636
[16]   PROSPECTIVE OBSERVATIONAL STUDY OF KLEBSIELLA BACTEREMIA IN 230 PATIENTS - OUTCOME FOR ANTIBIOTIC COMBINATIONS VERSUS MONOTHERAPY [J].
KORVICK, JA ;
BRYAN, CS ;
FARBER, B ;
BEAM, TR ;
SCHENFELD, L ;
MUDER, RR ;
WEINBAUM, D ;
LUMISH, R ;
GERDING, DN ;
WAGENER, MM ;
YU, VL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2639-2644
[17]   Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock [J].
Kumar, Arland ;
Roberts, Daniel ;
Wood, Kenneth E. ;
Light, Bruce ;
Parrillo, Joseph E. ;
Sharma, Satendra ;
Suppes, Robert ;
Feinstein, Daniel ;
Zanotti, Sergio ;
Taiberg, Leo ;
Gurka, David ;
Kumar, Aseem ;
Cheang, Mary .
CRITICAL CARE MEDICINE, 2006, 34 (06) :1589-1596
[18]  
Lai Chung-Hsu, 2004, Journal of Microbiology Immunology and Infection, V37, P350
[19]   Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region [J].
Laupland, K. B. ;
Gregson, D. B. ;
Church, D. L. ;
Ross, T. ;
Pitout, J. D. D. .
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (11) :1041-1047
[20]   Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: A prospective, observational study [J].
Leibovici, L ;
Paul, M ;
Poznanski, O ;
Drucker, M ;
Samra, Z ;
Konigsberger, H ;
Pitlik, SD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1127-1133